SD 282

Known as: SD-282, SD282 cpd 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2012
0246820022012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary inflammation, which is relatively insensitive to… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2008
2008
The effects of small-molecule p38 inhibitors in numerous models of different disease states have been published, including those… (More)
Is this relevant?
2008
2008
Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary inflammation, which is relatively insensitive to… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2006
2006
BACKGROUND AND PURPOSE Macrophages release cytokines that may contribute to pulmonary inflammation in conditions such as chronic… (More)
Is this relevant?
2006
2006
Transforming growth factor-beta (TGFbeta) is a major mediator of normal wound healing and of pathological conditions involving… (More)
Is this relevant?
2004
2004
Diabetes can induce a bewildering list of sensory changes, including alteration in pain sensitivity. Painful diabetic neuropathy… (More)
Is this relevant?
2004
2004
An active role for C-reactive protein (CRP) in inflammatory vascular diseases has been recently suggested. Monocytes play an… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
We examined the effect of p38 mitogen-activated protein kinase (MAPK) inhibitors in models of nociception and correlated this… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 6
Is this relevant?
2003
2003
Based on previous work, we hypothesized that activation of spinal NMDA-receptor initiates activation of the p38 mitogen-activated… (More)
Is this relevant?
2002
2002
beta-amyloid (A beta), derived form the beta-amyloid precursor protein (APP), is important for the pathogenesis of Alzheimer's… (More)
Is this relevant?